Skip to main content
. 2021 Nov 11;11:756440. doi: 10.3389/fonc.2021.756440

Table 6.

Metastatic site in the two groups.

Concurrent chemoradiotherapy (N/%) Surgery alone (N/%)
Local recurrence
 Anastomotic/residual stomach 6 (7.9) 14 (19.1)
 Regional tissue 2 (2.6) 6 (8.2)
Distant metastasis
 Lung 1 (1.3) 0
 Liver 3 (3.9) 6 (8.2)
 Bone 1 (1.3) 1 (1.4)
 Brain 0 1 (1.4)
 Peritoneum 17 (22.4) 15 (10.5)
 Distant lymph node 5 (6.6) 3 (4.1)
Total recurrence/distant metastases 30 (39.5) 39 (53.4)